Hot Sale Weight Loss Peptides 99% Purity Raw Material Liraglutide CAS 204656-20-2 for Type 2 Diabetes Treament and Weight Management

• CAS No.: 204656-20-2
• Formula: C172h265n43o51
• EINECS: 810-818-7
• Type: Peptides Powder
• Appearance: Powder
• Quality: Top Quality
• Model NO.: CAS 204656-20-2
• Colour: White
• Name: Liraglutide
• Mf: C172h265n43o51
• MW: 3751.202
• CAS: 810-818-7
• Packing: 1kg/Foil Bag or 25kgs/Drum
• Usage: for Research Use Only
• Transport Package: as Customer′s Requirement
• Specification: 1G/Foil bag
• Trademark: Redgia
• Origin: China

Product Description

Hot Sale Weight Loss Peptides 99% Purity Raw Material Liraglutide CAS 204656-20-2 For Type 2 Diabetes Treament And Weight Management

Product name	Liraglutide
Appearance	White powder
Purity	99%
Storage	Keep in a cool, dry, dark location in a tightly sealed container or cylinder.
Shelf Life	24 Months

Decription
 

Liraglutide (NN2211) is a long-acting gluca on-like peptide-1 receptor agonist, binding to the same receptors as
does the endogenous metabolic hormone GLP-1 that stimulates insuli secretion. Marketed under the brand name
Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo
Nordisk began marketing it in the U.S. under the brand name Saxend-a as a treatment for obesity in adults with at
least one weight-related comorbid condition.

Liraglutide was approved for treatment of type 2 diabetes by the European Medicines Agency (EMA) on July 3,
2009, and by the U.S. Food and Drug Administration (FDA) on January 25, 2010. More recently, Liraglutide was
approved by the FDA on December 23, 2014 for treatment for obesity in adults with some related comorbidity.

Application&Function

Liraglutide is a once-daily injectable derivative of the human incretin glucagon-like peptide-1 (GLP-1), for the
treatment of type 2 diabetes or obesity.

1.Treating type 2 diabetes.
2.Treating obesity.